Augmedix, Inc. ( AUGX) - Key Metrics
Stock symbol AUGX is outdated, potentially delisted? Maybe it is available on other exchange?
AUGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.26 | -$0.16 | -$0.07 | -$0.08 |
| 2024Q1 | $0.25 | -$0.12 | -$0.16 | -$0.17 |
| 2023Q4 | $0.26 | -$0.09 | -$0.02 | -$0.04 |
| 2023Q3 | $0.26 | -$0.10 | -$0.05 | -$0.06 |
| 2023Q2 | $0.25 | -$0.12 | -$0.14 | -$0.17 |
AUGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -1.47 |
| 2024Q1 | ? | -8.20 |
| 2023Q4 | ? | -15.96 |
| 2023Q3 | ? | -13.30 |
| 2023Q2 | ? | -10.42 |
AUGX
Price: $2.35
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NCM
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 112500
Market Capitalization: 115.2 million